Xenetic Biosciences マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Jim Parslow
最高経営責任者
US$433.7k
報酬総額
CEO給与比率 | 75.9% |
CEO在任期間 | 7.6yrs |
CEOの所有権 | n/a |
経営陣の平均在職期間 | データなし |
取締役会の平均在任期間 | 5.3yrs |
経営陣の近況
Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable
Dec 15Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All
Dec 01Recent updates
Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable
Dec 15Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All
Dec 01Xenetic Biosciences reports Q2 results
Aug 12Xenetic Biosciences, VolitionRx collaborate to develop cell therapies to treat cancer
Aug 02Xenetic inks clinical manufacturing contract with Catalent
Jul 07Xenetic Biosciences reports Q3 results
Nov 13CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$4m |
Jun 30 2024 | n/a | n/a | -US$5m |
Mar 31 2024 | n/a | n/a | -US$4m |
Dec 31 2023 | US$434k | US$329k | -US$4m |
Sep 30 2023 | n/a | n/a | -US$4m |
Jun 30 2023 | n/a | n/a | -US$4m |
Mar 31 2023 | n/a | n/a | -US$6m |
Dec 31 2022 | US$474k | US$329k | -US$7m |
Sep 30 2022 | n/a | n/a | -US$7m |
Jun 30 2022 | n/a | n/a | -US$7m |
Mar 31 2022 | n/a | n/a | -US$6m |
Dec 31 2021 | US$521k | US$299k | -US$6m |
Sep 30 2021 | n/a | n/a | -US$5m |
Jun 30 2021 | n/a | n/a | -US$11m |
Mar 31 2021 | n/a | n/a | -US$11m |
Dec 31 2020 | US$359k | US$285k | -US$11m |
Sep 30 2020 | n/a | n/a | -US$11m |
Jun 30 2020 | n/a | n/a | -US$14m |
Mar 31 2020 | n/a | n/a | -US$14m |
Dec 31 2019 | US$388k | US$265k | -US$18m |
Sep 30 2019 | n/a | n/a | -US$19m |
Jun 30 2019 | n/a | n/a | -US$10m |
Mar 31 2019 | n/a | n/a | -US$11m |
Dec 31 2018 | US$288k | US$265k | -US$7m |
Sep 30 2018 | n/a | n/a | -US$1m |
Jun 30 2018 | n/a | n/a | -US$2m |
Mar 31 2018 | n/a | n/a | -US$3m |
Dec 31 2017 | US$960k | US$199k | -US$4m |
報酬と市場: Jimの 総報酬 ($USD 433.73K ) は、 US市場 ($USD 650.80K ) の同様の規模の企業の平均を下回っています。
報酬と収益: Jimの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Jim Parslow (59 yo)
7.6yrs
在職期間
US$433,732
報酬
Mr. James F. Parslow, also known as Jim, has been Chief Financial Officer at Xenetic Biosciences, Inc. since April 03, 2017 and serves as its Chief Operating Officer and Corporate Secretary and serves as i...
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
President & Director | 8.3yrs | US$563.49k | 0.027% $ 1.7k | |
Independent Non Executive Director | less than a year | US$12.33k | 0% $ 0 | |
Independent Director | 8.8yrs | US$57.54k | 0% $ 0 | |
Independent Director | 10.8yrs | US$57.54k | 0% $ 0 | |
Non-Executive Director | less than a year | データなし | 4.44% $ 281.0k | |
Member of Scientific Advisory Board | 5.5yrs | データなし | データなし | |
Member of Scientific Advisory Board | 5.8yrs | データなし | データなし | |
Independent Director | 5.3yrs | US$57.54k | データなし | |
Independent Non-Executive Director | 5.2yrs | US$57.54k | 0% $ 0 | |
Member of Scientific Advisory Board | 4.8yrs | データなし | データなし | |
Member of Scientific Advisory Board | 2.5yrs | データなし | データなし | |
Member of Scientific Advisory Board | 2yrs | データなし | データなし |
5.3yrs
平均在職期間
58yo
平均年齢
経験豊富なボード: XBIOの 取締役会 は 経験豊富 であると考えられます ( 5.3年の平均在任期間)。